Skip to content
MedsAcross

Brand family

Tracleer

Bosentan · Actelion Pharmaceuticals
United States
Presentations
3
Markets
1

Tracleer is a brand of Bosentan marketed by Actelion Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Bosentan
Brand owner
Actelion Pharmaceuticals
Registered in
United States
Strengths and forms
125 mg tablet, 62.5 mg tablet, 32 mg tablet for oral suspension

All presentations

MedicineManufacturerRegisterAvailability
Tracleer 125 mg tabletOralActelion PharmaceuticalsUS FDAAvailable on request
Tracleer 62.5 mg tabletOralActelion PharmaceuticalsUS FDAAvailable on request
Tracleer 32 mg tablet for oral suspensionOralActelion PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Tracleer

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.